Invesco
CGON icon

Invesco’s CG Oncology CGON Stock Holding History

Invesco’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.23M Buy
91,994
+53,854
+141% +$3.05M ﹤0.01% 2090
2025
Q4 		$1.58M Buy
38,140
+3,761
+11% +$156K ﹤0.01% 2706
2025
Q3 		$1.38M Buy
34,379
+5,148
+18% +$150K ﹤0.01% 2781
2025
Q2 		$760K Buy
29,231
+1,477
+5% +$35.6K ﹤0.01% 2972
2025
Q1 		$680K Buy
27,754
+685
+3% +$19.3K ﹤0.01% 3026
2024
Q4 		$776K Buy
27,069
+11,662
+76% +$399K ﹤0.01% 3021
2024
Q3 		$581K Buy
15,407
+3,001
+24% +$105K ﹤0.01% 3168
2024
Q2 		$392K Buy
12,406
+223
+2% +$7.73K ﹤0.01% 3378
2024
Q1 		$535K Buy
+12,183
New +$498K ﹤0.01% 3297

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM